Tumoral pyruvate kinase L/R as a predictive marker for the treatment of renal cancer patients with sunitinib and sorafenib

2018

Tumoral pyruvate kinase L/R as a predictive marker for the treatment of renal cancer patients with sunitinib and sorafenib

Keywords:

Correction
Source
Cite
Save
Machine Reading By IdeaReader

35

References

5

Citations